Global Circulating Tumor DNA Test Kit Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global DSA Imaging Operating Bed market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
As vascular interventional surgery continues to become more popular, the demand for DSA imaging operating beds is also increasing. The DSA imaging operating bed can provide high-definition angiography images to help doctors diagnose and formulate surgical plans more accurately, thereby improving the accuracy and safety of surgery. In the future, with the widespread application of vascular interventional surgeries, the market demand for DSA imaging operating beds will continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “DSA Imaging Operating Bed Industry Forecast” looks at past sales and reviews total world DSA Imaging Operating Bed sales in 2024, providing a comprehensive analysis by region and market sector of projected DSA Imaging Operating Bed sales for 2025 through 2031. With DSA Imaging Operating Bed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DSA Imaging Operating Bed industry.
This Insight Report provides a comprehensive analysis of the global DSA Imaging Operating Bed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DSA Imaging Operating Bed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DSA Imaging Operating Bed market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DSA Imaging Operating Bed and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DSA Imaging Operating Bed.
This report presents a comprehensive overview, market shares, and growth opportunities of DSA Imaging Operating Bed market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global DSA Imaging Operating Bed market?
What factors are driving DSA Imaging Operating Bed market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DSA Imaging Operating Bed market opportunities vary by end market size?
How does DSA Imaging Operating Bed break out by Type, by Application?
The global DSA Imaging Operating Bed market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
As vascular interventional surgery continues to become more popular, the demand for DSA imaging operating beds is also increasing. The DSA imaging operating bed can provide high-definition angiography images to help doctors diagnose and formulate surgical plans more accurately, thereby improving the accuracy and safety of surgery. In the future, with the widespread application of vascular interventional surgeries, the market demand for DSA imaging operating beds will continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “DSA Imaging Operating Bed Industry Forecast” looks at past sales and reviews total world DSA Imaging Operating Bed sales in 2024, providing a comprehensive analysis by region and market sector of projected DSA Imaging Operating Bed sales for 2025 through 2031. With DSA Imaging Operating Bed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DSA Imaging Operating Bed industry.
This Insight Report provides a comprehensive analysis of the global DSA Imaging Operating Bed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DSA Imaging Operating Bed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DSA Imaging Operating Bed market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DSA Imaging Operating Bed and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DSA Imaging Operating Bed.
This report presents a comprehensive overview, market shares, and growth opportunities of DSA Imaging Operating Bed market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Flat-Panel DSA Angiography Operating Table
- Suspended DSA Angiography Operating Table
- Operating Room
- ICU
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AADCO Medical
- ALVO Medical
- BIODEX
- Infimed
- Infinium
- Mizuho OSI
- Medifa
- Schaerer
- Allengers
- Ima-x
What is the 10-year outlook for the global DSA Imaging Operating Bed market?
What factors are driving DSA Imaging Operating Bed market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DSA Imaging Operating Bed market opportunities vary by end market size?
How does DSA Imaging Operating Bed break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor DNA Test Kit Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Circulating Tumor DNA Test Kit by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Circulating Tumor DNA Test Kit by Country/Region, 2020, 2024 & 2031
2.2 Circulating Tumor DNA Test Kit Segment by Type
2.2.1 Blood Cancer
2.2.2 Solid Tumor
2.3 Circulating Tumor DNA Test Kit Sales by Type
2.3.1 Global Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
2.3.2 Global Circulating Tumor DNA Test Kit Revenue and Market Share by Type (2020-2025)
2.3.3 Global Circulating Tumor DNA Test Kit Sale Price by Type (2020-2025)
2.4 Circulating Tumor DNA Test Kit Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Circulating Tumor DNA Test Kit Sales by Application
2.5.1 Global Circulating Tumor DNA Test Kit Sale Market Share by Application (2020-2025)
2.5.2 Global Circulating Tumor DNA Test Kit Revenue and Market Share by Application (2020-2025)
2.5.3 Global Circulating Tumor DNA Test Kit Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Circulating Tumor DNA Test Kit Breakdown Data by Company
3.1.1 Global Circulating Tumor DNA Test Kit Annual Sales by Company (2020-2025)
3.1.2 Global Circulating Tumor DNA Test Kit Sales Market Share by Company (2020-2025)
3.2 Global Circulating Tumor DNA Test Kit Annual Revenue by Company (2020-2025)
3.2.1 Global Circulating Tumor DNA Test Kit Revenue by Company (2020-2025)
3.2.2 Global Circulating Tumor DNA Test Kit Revenue Market Share by Company (2020-2025)
3.3 Global Circulating Tumor DNA Test Kit Sale Price by Company
3.4 Key Manufacturers Circulating Tumor DNA Test Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Circulating Tumor DNA Test Kit Product Location Distribution
3.4.2 Players Circulating Tumor DNA Test Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CIRCULATING TUMOR DNA TEST KIT BY GEOGRAPHIC REGION
4.1 World Historic Circulating Tumor DNA Test Kit Market Size by Geographic Region (2020-2025)
4.1.1 Global Circulating Tumor DNA Test Kit Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Circulating Tumor DNA Test Kit Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Circulating Tumor DNA Test Kit Market Size by Country/Region (2020-2025)
4.2.1 Global Circulating Tumor DNA Test Kit Annual Sales by Country/Region (2020-2025)
4.2.2 Global Circulating Tumor DNA Test Kit Annual Revenue by Country/Region (2020-2025)
4.3 Americas Circulating Tumor DNA Test Kit Sales Growth
4.4 APAC Circulating Tumor DNA Test Kit Sales Growth
4.5 Europe Circulating Tumor DNA Test Kit Sales Growth
4.6 Middle East & Africa Circulating Tumor DNA Test Kit Sales Growth
5 AMERICAS
5.1 Americas Circulating Tumor DNA Test Kit Sales by Country
5.1.1 Americas Circulating Tumor DNA Test Kit Sales by Country (2020-2025)
5.1.2 Americas Circulating Tumor DNA Test Kit Revenue by Country (2020-2025)
5.2 Americas Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
5.3 Americas Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor DNA Test Kit Sales by Region
6.1.1 APAC Circulating Tumor DNA Test Kit Sales by Region (2020-2025)
6.1.2 APAC Circulating Tumor DNA Test Kit Revenue by Region (2020-2025)
6.2 APAC Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
6.3 APAC Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Circulating Tumor DNA Test Kit by Country
7.1.1 Europe Circulating Tumor DNA Test Kit Sales by Country (2020-2025)
7.1.2 Europe Circulating Tumor DNA Test Kit Revenue by Country (2020-2025)
7.2 Europe Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
7.3 Europe Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor DNA Test Kit by Country
8.1.1 Middle East & Africa Circulating Tumor DNA Test Kit Sales by Country (2020-2025)
8.1.2 Middle East & Africa Circulating Tumor DNA Test Kit Revenue by Country (2020-2025)
8.2 Middle East & Africa Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
8.3 Middle East & Africa Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Circulating Tumor DNA Test Kit
10.3 Manufacturing Process Analysis of Circulating Tumor DNA Test Kit
10.4 Industry Chain Structure of Circulating Tumor DNA Test Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Circulating Tumor DNA Test Kit Distributors
11.3 Circulating Tumor DNA Test Kit Customer
12 WORLD FORECAST REVIEW FOR CIRCULATING TUMOR DNA TEST KIT BY GEOGRAPHIC REGION
12.1 Global Circulating Tumor DNA Test Kit Market Size Forecast by Region
12.1.1 Global Circulating Tumor DNA Test Kit Forecast by Region (2026-2031)
12.1.2 Global Circulating Tumor DNA Test Kit Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Circulating Tumor DNA Test Kit Forecast by Type (2026-2031)
12.7 Global Circulating Tumor DNA Test Kit Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Grail, Inc.
13.1.1 Grail, Inc. Company Information
13.1.2 Grail, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.1.3 Grail, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Grail, Inc. Main Business Overview
13.1.5 Grail, Inc. Latest Developments
13.2 Guardant Health, Inc.
13.2.1 Guardant Health, Inc. Company Information
13.2.2 Guardant Health, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.2.3 Guardant Health, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Guardant Health, Inc. Main Business Overview
13.2.5 Guardant Health, Inc. Latest Developments
13.3 Biodesix, Inc.
13.3.1 Biodesix, Inc. Company Information
13.3.2 Biodesix, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.3.3 Biodesix, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biodesix, Inc. Main Business Overview
13.3.5 Biodesix, Inc. Latest Developments
13.4 Exosome Diagnostics
13.4.1 Exosome Diagnostics Company Information
13.4.2 Exosome Diagnostics Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.4.3 Exosome Diagnostics Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Exosome Diagnostics Main Business Overview
13.4.5 Exosome Diagnostics Latest Developments
13.5 Freenome Inc.
13.5.1 Freenome Inc. Company Information
13.5.2 Freenome Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.5.3 Freenome Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Freenome Inc. Main Business Overview
13.5.5 Freenome Inc. Latest Developments
13.6 LungLife AI, Inc.
13.6.1 LungLife AI, Inc. Company Information
13.6.2 LungLife AI, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.6.3 LungLife AI, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 LungLife AI, Inc. Main Business Overview
13.6.5 LungLife AI, Inc. Latest Developments
13.7 Inivata Ltd.
13.7.1 Inivata Ltd. Company Information
13.7.2 Inivata Ltd. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.7.3 Inivata Ltd. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Inivata Ltd. Main Business Overview
13.7.5 Inivata Ltd. Latest Developments
13.8 Personal Genome Diagnostics, Inc.
13.8.1 Personal Genome Diagnostics, Inc. Company Information
13.8.2 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.8.3 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Personal Genome Diagnostics, Inc. Main Business Overview
13.8.5 Personal Genome Diagnostics, Inc. Latest Developments
13.9 CellMax Life
13.9.1 CellMax Life Company Information
13.9.2 CellMax Life Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.9.3 CellMax Life Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CellMax Life Main Business Overview
13.9.5 CellMax Life Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor DNA Test Kit Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Circulating Tumor DNA Test Kit by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Circulating Tumor DNA Test Kit by Country/Region, 2020, 2024 & 2031
2.2 Circulating Tumor DNA Test Kit Segment by Type
2.2.1 Blood Cancer
2.2.2 Solid Tumor
2.3 Circulating Tumor DNA Test Kit Sales by Type
2.3.1 Global Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
2.3.2 Global Circulating Tumor DNA Test Kit Revenue and Market Share by Type (2020-2025)
2.3.3 Global Circulating Tumor DNA Test Kit Sale Price by Type (2020-2025)
2.4 Circulating Tumor DNA Test Kit Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Circulating Tumor DNA Test Kit Sales by Application
2.5.1 Global Circulating Tumor DNA Test Kit Sale Market Share by Application (2020-2025)
2.5.2 Global Circulating Tumor DNA Test Kit Revenue and Market Share by Application (2020-2025)
2.5.3 Global Circulating Tumor DNA Test Kit Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Circulating Tumor DNA Test Kit Breakdown Data by Company
3.1.1 Global Circulating Tumor DNA Test Kit Annual Sales by Company (2020-2025)
3.1.2 Global Circulating Tumor DNA Test Kit Sales Market Share by Company (2020-2025)
3.2 Global Circulating Tumor DNA Test Kit Annual Revenue by Company (2020-2025)
3.2.1 Global Circulating Tumor DNA Test Kit Revenue by Company (2020-2025)
3.2.2 Global Circulating Tumor DNA Test Kit Revenue Market Share by Company (2020-2025)
3.3 Global Circulating Tumor DNA Test Kit Sale Price by Company
3.4 Key Manufacturers Circulating Tumor DNA Test Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Circulating Tumor DNA Test Kit Product Location Distribution
3.4.2 Players Circulating Tumor DNA Test Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CIRCULATING TUMOR DNA TEST KIT BY GEOGRAPHIC REGION
4.1 World Historic Circulating Tumor DNA Test Kit Market Size by Geographic Region (2020-2025)
4.1.1 Global Circulating Tumor DNA Test Kit Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Circulating Tumor DNA Test Kit Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Circulating Tumor DNA Test Kit Market Size by Country/Region (2020-2025)
4.2.1 Global Circulating Tumor DNA Test Kit Annual Sales by Country/Region (2020-2025)
4.2.2 Global Circulating Tumor DNA Test Kit Annual Revenue by Country/Region (2020-2025)
4.3 Americas Circulating Tumor DNA Test Kit Sales Growth
4.4 APAC Circulating Tumor DNA Test Kit Sales Growth
4.5 Europe Circulating Tumor DNA Test Kit Sales Growth
4.6 Middle East & Africa Circulating Tumor DNA Test Kit Sales Growth
5 AMERICAS
5.1 Americas Circulating Tumor DNA Test Kit Sales by Country
5.1.1 Americas Circulating Tumor DNA Test Kit Sales by Country (2020-2025)
5.1.2 Americas Circulating Tumor DNA Test Kit Revenue by Country (2020-2025)
5.2 Americas Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
5.3 Americas Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor DNA Test Kit Sales by Region
6.1.1 APAC Circulating Tumor DNA Test Kit Sales by Region (2020-2025)
6.1.2 APAC Circulating Tumor DNA Test Kit Revenue by Region (2020-2025)
6.2 APAC Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
6.3 APAC Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Circulating Tumor DNA Test Kit by Country
7.1.1 Europe Circulating Tumor DNA Test Kit Sales by Country (2020-2025)
7.1.2 Europe Circulating Tumor DNA Test Kit Revenue by Country (2020-2025)
7.2 Europe Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
7.3 Europe Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor DNA Test Kit by Country
8.1.1 Middle East & Africa Circulating Tumor DNA Test Kit Sales by Country (2020-2025)
8.1.2 Middle East & Africa Circulating Tumor DNA Test Kit Revenue by Country (2020-2025)
8.2 Middle East & Africa Circulating Tumor DNA Test Kit Sales by Type (2020-2025)
8.3 Middle East & Africa Circulating Tumor DNA Test Kit Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Circulating Tumor DNA Test Kit
10.3 Manufacturing Process Analysis of Circulating Tumor DNA Test Kit
10.4 Industry Chain Structure of Circulating Tumor DNA Test Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Circulating Tumor DNA Test Kit Distributors
11.3 Circulating Tumor DNA Test Kit Customer
12 WORLD FORECAST REVIEW FOR CIRCULATING TUMOR DNA TEST KIT BY GEOGRAPHIC REGION
12.1 Global Circulating Tumor DNA Test Kit Market Size Forecast by Region
12.1.1 Global Circulating Tumor DNA Test Kit Forecast by Region (2026-2031)
12.1.2 Global Circulating Tumor DNA Test Kit Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Circulating Tumor DNA Test Kit Forecast by Type (2026-2031)
12.7 Global Circulating Tumor DNA Test Kit Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Grail, Inc.
13.1.1 Grail, Inc. Company Information
13.1.2 Grail, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.1.3 Grail, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Grail, Inc. Main Business Overview
13.1.5 Grail, Inc. Latest Developments
13.2 Guardant Health, Inc.
13.2.1 Guardant Health, Inc. Company Information
13.2.2 Guardant Health, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.2.3 Guardant Health, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Guardant Health, Inc. Main Business Overview
13.2.5 Guardant Health, Inc. Latest Developments
13.3 Biodesix, Inc.
13.3.1 Biodesix, Inc. Company Information
13.3.2 Biodesix, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.3.3 Biodesix, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biodesix, Inc. Main Business Overview
13.3.5 Biodesix, Inc. Latest Developments
13.4 Exosome Diagnostics
13.4.1 Exosome Diagnostics Company Information
13.4.2 Exosome Diagnostics Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.4.3 Exosome Diagnostics Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Exosome Diagnostics Main Business Overview
13.4.5 Exosome Diagnostics Latest Developments
13.5 Freenome Inc.
13.5.1 Freenome Inc. Company Information
13.5.2 Freenome Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.5.3 Freenome Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Freenome Inc. Main Business Overview
13.5.5 Freenome Inc. Latest Developments
13.6 LungLife AI, Inc.
13.6.1 LungLife AI, Inc. Company Information
13.6.2 LungLife AI, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.6.3 LungLife AI, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 LungLife AI, Inc. Main Business Overview
13.6.5 LungLife AI, Inc. Latest Developments
13.7 Inivata Ltd.
13.7.1 Inivata Ltd. Company Information
13.7.2 Inivata Ltd. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.7.3 Inivata Ltd. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Inivata Ltd. Main Business Overview
13.7.5 Inivata Ltd. Latest Developments
13.8 Personal Genome Diagnostics, Inc.
13.8.1 Personal Genome Diagnostics, Inc. Company Information
13.8.2 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.8.3 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Personal Genome Diagnostics, Inc. Main Business Overview
13.8.5 Personal Genome Diagnostics, Inc. Latest Developments
13.9 CellMax Life
13.9.1 CellMax Life Company Information
13.9.2 CellMax Life Circulating Tumor DNA Test Kit Product Portfolios and Specifications
13.9.3 CellMax Life Circulating Tumor DNA Test Kit Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CellMax Life Main Business Overview
13.9.5 CellMax Life Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Circulating Tumor DNA Test Kit Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Circulating Tumor DNA Test Kit Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Blood Cancer
Table 4. Major Players of Solid Tumor
Table 5. Global Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 6. Global Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Table 7. Global Circulating Tumor DNA Test Kit Revenue by Type (2020-2025) & ($ million)
Table 8. Global Circulating Tumor DNA Test Kit Revenue Market Share by Type (2020-2025)
Table 9. Global Circulating Tumor DNA Test Kit Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Circulating Tumor DNA Test Kit Sale by Application (2020-2025) & (K Units)
Table 11. Global Circulating Tumor DNA Test Kit Sale Market Share by Application (2020-2025)
Table 12. Global Circulating Tumor DNA Test Kit Revenue by Application (2020-2025) & ($ million)
Table 13. Global Circulating Tumor DNA Test Kit Revenue Market Share by Application (2020-2025)
Table 14. Global Circulating Tumor DNA Test Kit Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Circulating Tumor DNA Test Kit Sales by Company (2020-2025) & (K Units)
Table 16. Global Circulating Tumor DNA Test Kit Sales Market Share by Company (2020-2025)
Table 17. Global Circulating Tumor DNA Test Kit Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Circulating Tumor DNA Test Kit Revenue Market Share by Company (2020-2025)
Table 19. Global Circulating Tumor DNA Test Kit Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Circulating Tumor DNA Test Kit Producing Area Distribution and Sales Area
Table 21. Players Circulating Tumor DNA Test Kit Products Offered
Table 22. Circulating Tumor DNA Test Kit Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Circulating Tumor DNA Test Kit Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Circulating Tumor DNA Test Kit Sales Market Share Geographic Region (2020-2025)
Table 27. Global Circulating Tumor DNA Test Kit Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Circulating Tumor DNA Test Kit Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Circulating Tumor DNA Test Kit Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Circulating Tumor DNA Test Kit Sales Market Share by Country/Region (2020-2025)
Table 31. Global Circulating Tumor DNA Test Kit Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Circulating Tumor DNA Test Kit Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Circulating Tumor DNA Test Kit Sales by Country (2020-2025) & (K Units)
Table 34. Americas Circulating Tumor DNA Test Kit Sales Market Share by Country (2020-2025)
Table 35. Americas Circulating Tumor DNA Test Kit Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 37. Americas Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 38. APAC Circulating Tumor DNA Test Kit Sales by Region (2020-2025) & (K Units)
Table 39. APAC Circulating Tumor DNA Test Kit Sales Market Share by Region (2020-2025)
Table 40. APAC Circulating Tumor DNA Test Kit Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 42. APAC Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 43. Europe Circulating Tumor DNA Test Kit Sales by Country (2020-2025) & (K Units)
Table 44. Europe Circulating Tumor DNA Test Kit Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 46. Europe Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Circulating Tumor DNA Test Kit Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Circulating Tumor DNA Test Kit Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Circulating Tumor DNA Test Kit
Table 52. Key Market Challenges & Risks of Circulating Tumor DNA Test Kit
Table 53. Key Industry Trends of Circulating Tumor DNA Test Kit
Table 54. Circulating Tumor DNA Test Kit Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Circulating Tumor DNA Test Kit Distributors List
Table 57. Circulating Tumor DNA Test Kit Customer List
Table 58. Global Circulating Tumor DNA Test Kit Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Circulating Tumor DNA Test Kit Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Circulating Tumor DNA Test Kit Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Circulating Tumor DNA Test Kit Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Circulating Tumor DNA Test Kit Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Circulating Tumor DNA Test Kit Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Circulating Tumor DNA Test Kit Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Circulating Tumor DNA Test Kit Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Circulating Tumor DNA Test Kit Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Circulating Tumor DNA Test Kit Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Circulating Tumor DNA Test Kit Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Circulating Tumor DNA Test Kit Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Circulating Tumor DNA Test Kit Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Circulating Tumor DNA Test Kit Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Grail, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 73. Grail, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 74. Grail, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Grail, Inc. Main Business
Table 76. Grail, Inc. Latest Developments
Table 77. Guardant Health, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 78. Guardant Health, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 79. Guardant Health, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Guardant Health, Inc. Main Business
Table 81. Guardant Health, Inc. Latest Developments
Table 82. Biodesix, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 83. Biodesix, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 84. Biodesix, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Biodesix, Inc. Main Business
Table 86. Biodesix, Inc. Latest Developments
Table 87. Exosome Diagnostics Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 88. Exosome Diagnostics Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 89. Exosome Diagnostics Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Exosome Diagnostics Main Business
Table 91. Exosome Diagnostics Latest Developments
Table 92. Freenome Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 93. Freenome Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 94. Freenome Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Freenome Inc. Main Business
Table 96. Freenome Inc. Latest Developments
Table 97. LungLife AI, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 98. LungLife AI, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 99. LungLife AI, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. LungLife AI, Inc. Main Business
Table 101. LungLife AI, Inc. Latest Developments
Table 102. Inivata Ltd. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 103. Inivata Ltd. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 104. Inivata Ltd. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Inivata Ltd. Main Business
Table 106. Inivata Ltd. Latest Developments
Table 107. Personal Genome Diagnostics, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 108. Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 109. Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Personal Genome Diagnostics, Inc. Main Business
Table 111. Personal Genome Diagnostics, Inc. Latest Developments
Table 112. CellMax Life Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 113. CellMax Life Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 114. CellMax Life Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. CellMax Life Main Business
Table 116. CellMax Life Latest Developments
Table 1. Circulating Tumor DNA Test Kit Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Circulating Tumor DNA Test Kit Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Blood Cancer
Table 4. Major Players of Solid Tumor
Table 5. Global Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 6. Global Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Table 7. Global Circulating Tumor DNA Test Kit Revenue by Type (2020-2025) & ($ million)
Table 8. Global Circulating Tumor DNA Test Kit Revenue Market Share by Type (2020-2025)
Table 9. Global Circulating Tumor DNA Test Kit Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Circulating Tumor DNA Test Kit Sale by Application (2020-2025) & (K Units)
Table 11. Global Circulating Tumor DNA Test Kit Sale Market Share by Application (2020-2025)
Table 12. Global Circulating Tumor DNA Test Kit Revenue by Application (2020-2025) & ($ million)
Table 13. Global Circulating Tumor DNA Test Kit Revenue Market Share by Application (2020-2025)
Table 14. Global Circulating Tumor DNA Test Kit Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Circulating Tumor DNA Test Kit Sales by Company (2020-2025) & (K Units)
Table 16. Global Circulating Tumor DNA Test Kit Sales Market Share by Company (2020-2025)
Table 17. Global Circulating Tumor DNA Test Kit Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Circulating Tumor DNA Test Kit Revenue Market Share by Company (2020-2025)
Table 19. Global Circulating Tumor DNA Test Kit Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Circulating Tumor DNA Test Kit Producing Area Distribution and Sales Area
Table 21. Players Circulating Tumor DNA Test Kit Products Offered
Table 22. Circulating Tumor DNA Test Kit Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Circulating Tumor DNA Test Kit Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Circulating Tumor DNA Test Kit Sales Market Share Geographic Region (2020-2025)
Table 27. Global Circulating Tumor DNA Test Kit Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Circulating Tumor DNA Test Kit Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Circulating Tumor DNA Test Kit Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Circulating Tumor DNA Test Kit Sales Market Share by Country/Region (2020-2025)
Table 31. Global Circulating Tumor DNA Test Kit Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Circulating Tumor DNA Test Kit Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Circulating Tumor DNA Test Kit Sales by Country (2020-2025) & (K Units)
Table 34. Americas Circulating Tumor DNA Test Kit Sales Market Share by Country (2020-2025)
Table 35. Americas Circulating Tumor DNA Test Kit Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 37. Americas Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 38. APAC Circulating Tumor DNA Test Kit Sales by Region (2020-2025) & (K Units)
Table 39. APAC Circulating Tumor DNA Test Kit Sales Market Share by Region (2020-2025)
Table 40. APAC Circulating Tumor DNA Test Kit Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 42. APAC Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 43. Europe Circulating Tumor DNA Test Kit Sales by Country (2020-2025) & (K Units)
Table 44. Europe Circulating Tumor DNA Test Kit Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 46. Europe Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Circulating Tumor DNA Test Kit Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Circulating Tumor DNA Test Kit Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Circulating Tumor DNA Test Kit Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Circulating Tumor DNA Test Kit Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Circulating Tumor DNA Test Kit
Table 52. Key Market Challenges & Risks of Circulating Tumor DNA Test Kit
Table 53. Key Industry Trends of Circulating Tumor DNA Test Kit
Table 54. Circulating Tumor DNA Test Kit Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Circulating Tumor DNA Test Kit Distributors List
Table 57. Circulating Tumor DNA Test Kit Customer List
Table 58. Global Circulating Tumor DNA Test Kit Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Circulating Tumor DNA Test Kit Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Circulating Tumor DNA Test Kit Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Circulating Tumor DNA Test Kit Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Circulating Tumor DNA Test Kit Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Circulating Tumor DNA Test Kit Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Circulating Tumor DNA Test Kit Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Circulating Tumor DNA Test Kit Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Circulating Tumor DNA Test Kit Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Circulating Tumor DNA Test Kit Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Circulating Tumor DNA Test Kit Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Circulating Tumor DNA Test Kit Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Circulating Tumor DNA Test Kit Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Circulating Tumor DNA Test Kit Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Grail, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 73. Grail, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 74. Grail, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Grail, Inc. Main Business
Table 76. Grail, Inc. Latest Developments
Table 77. Guardant Health, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 78. Guardant Health, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 79. Guardant Health, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Guardant Health, Inc. Main Business
Table 81. Guardant Health, Inc. Latest Developments
Table 82. Biodesix, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 83. Biodesix, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 84. Biodesix, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Biodesix, Inc. Main Business
Table 86. Biodesix, Inc. Latest Developments
Table 87. Exosome Diagnostics Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 88. Exosome Diagnostics Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 89. Exosome Diagnostics Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Exosome Diagnostics Main Business
Table 91. Exosome Diagnostics Latest Developments
Table 92. Freenome Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 93. Freenome Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 94. Freenome Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Freenome Inc. Main Business
Table 96. Freenome Inc. Latest Developments
Table 97. LungLife AI, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 98. LungLife AI, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 99. LungLife AI, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. LungLife AI, Inc. Main Business
Table 101. LungLife AI, Inc. Latest Developments
Table 102. Inivata Ltd. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 103. Inivata Ltd. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 104. Inivata Ltd. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Inivata Ltd. Main Business
Table 106. Inivata Ltd. Latest Developments
Table 107. Personal Genome Diagnostics, Inc. Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 108. Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 109. Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Personal Genome Diagnostics, Inc. Main Business
Table 111. Personal Genome Diagnostics, Inc. Latest Developments
Table 112. CellMax Life Basic Information, Circulating Tumor DNA Test Kit Manufacturing Base, Sales Area and Its Competitors
Table 113. CellMax Life Circulating Tumor DNA Test Kit Product Portfolios and Specifications
Table 114. CellMax Life Circulating Tumor DNA Test Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. CellMax Life Main Business
Table 116. CellMax Life Latest Developments
LIST OF FIGURES
Figure 1. Picture of Circulating Tumor DNA Test Kit
Figure 2. Circulating Tumor DNA Test Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Circulating Tumor DNA Test Kit Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Circulating Tumor DNA Test Kit Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Circulating Tumor DNA Test Kit Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Circulating Tumor DNA Test Kit Sales Market Share by Country/Region (2024)
Figure 10. Circulating Tumor DNA Test Kit Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Blood Cancer
Figure 12. Product Picture of Solid Tumor
Figure 13. Global Circulating Tumor DNA Test Kit Sales Market Share by Type in 2025
Figure 14. Global Circulating Tumor DNA Test Kit Revenue Market Share by Type (2020-2025)
Figure 15. Circulating Tumor DNA Test Kit Consumed in Hospital
Figure 16. Global Circulating Tumor DNA Test Kit Market: Hospital (2020-2025) & (K Units)
Figure 17. Circulating Tumor DNA Test Kit Consumed in Clinic
Figure 18. Global Circulating Tumor DNA Test Kit Market: Clinic (2020-2025) & (K Units)
Figure 19. Circulating Tumor DNA Test Kit Consumed in Others
Figure 20. Global Circulating Tumor DNA Test Kit Market: Others (2020-2025) & (K Units)
Figure 21. Global Circulating Tumor DNA Test Kit Sale Market Share by Application (2024)
Figure 22. Global Circulating Tumor DNA Test Kit Revenue Market Share by Application in 2025
Figure 23. Circulating Tumor DNA Test Kit Sales by Company in 2025 (K Units)
Figure 24. Global Circulating Tumor DNA Test Kit Sales Market Share by Company in 2025
Figure 25. Circulating Tumor DNA Test Kit Revenue by Company in 2025 ($ millions)
Figure 26. Global Circulating Tumor DNA Test Kit Revenue Market Share by Company in 2025
Figure 27. Global Circulating Tumor DNA Test Kit Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Circulating Tumor DNA Test Kit Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 30. Americas Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 31. APAC Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 32. APAC Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 33. Europe Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 34. Europe Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 37. Americas Circulating Tumor DNA Test Kit Sales Market Share by Country in 2025
Figure 38. Americas Circulating Tumor DNA Test Kit Revenue Market Share by Country (2020-2025)
Figure 39. Americas Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 40. Americas Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 41. United States Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Circulating Tumor DNA Test Kit Sales Market Share by Region in 2025
Figure 46. APAC Circulating Tumor DNA Test Kit Revenue Market Share by Region (2020-2025)
Figure 47. APAC Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 48. APAC Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 49. China Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 53. India Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Circulating Tumor DNA Test Kit Sales Market Share by Country in 2025
Figure 57. Europe Circulating Tumor DNA Test Kit Revenue Market Share by Country (2020-2025)
Figure 58. Europe Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 59. Europe Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 60. Germany Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 61. France Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Circulating Tumor DNA Test Kit Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 68. Egypt Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Circulating Tumor DNA Test Kit in 2025
Figure 74. Manufacturing Process Analysis of Circulating Tumor DNA Test Kit
Figure 75. Industry Chain Structure of Circulating Tumor DNA Test Kit
Figure 76. Channels of Distribution
Figure 77. Global Circulating Tumor DNA Test Kit Sales Market Forecast by Region (2026-2031)
Figure 78. Global Circulating Tumor DNA Test Kit Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Circulating Tumor DNA Test Kit Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Circulating Tumor DNA Test Kit Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Circulating Tumor DNA Test Kit Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Circulating Tumor DNA Test Kit Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Circulating Tumor DNA Test Kit
Figure 2. Circulating Tumor DNA Test Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Circulating Tumor DNA Test Kit Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Circulating Tumor DNA Test Kit Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Circulating Tumor DNA Test Kit Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Circulating Tumor DNA Test Kit Sales Market Share by Country/Region (2024)
Figure 10. Circulating Tumor DNA Test Kit Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Blood Cancer
Figure 12. Product Picture of Solid Tumor
Figure 13. Global Circulating Tumor DNA Test Kit Sales Market Share by Type in 2025
Figure 14. Global Circulating Tumor DNA Test Kit Revenue Market Share by Type (2020-2025)
Figure 15. Circulating Tumor DNA Test Kit Consumed in Hospital
Figure 16. Global Circulating Tumor DNA Test Kit Market: Hospital (2020-2025) & (K Units)
Figure 17. Circulating Tumor DNA Test Kit Consumed in Clinic
Figure 18. Global Circulating Tumor DNA Test Kit Market: Clinic (2020-2025) & (K Units)
Figure 19. Circulating Tumor DNA Test Kit Consumed in Others
Figure 20. Global Circulating Tumor DNA Test Kit Market: Others (2020-2025) & (K Units)
Figure 21. Global Circulating Tumor DNA Test Kit Sale Market Share by Application (2024)
Figure 22. Global Circulating Tumor DNA Test Kit Revenue Market Share by Application in 2025
Figure 23. Circulating Tumor DNA Test Kit Sales by Company in 2025 (K Units)
Figure 24. Global Circulating Tumor DNA Test Kit Sales Market Share by Company in 2025
Figure 25. Circulating Tumor DNA Test Kit Revenue by Company in 2025 ($ millions)
Figure 26. Global Circulating Tumor DNA Test Kit Revenue Market Share by Company in 2025
Figure 27. Global Circulating Tumor DNA Test Kit Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Circulating Tumor DNA Test Kit Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 30. Americas Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 31. APAC Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 32. APAC Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 33. Europe Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 34. Europe Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Circulating Tumor DNA Test Kit Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Circulating Tumor DNA Test Kit Revenue 2020-2025 ($ millions)
Figure 37. Americas Circulating Tumor DNA Test Kit Sales Market Share by Country in 2025
Figure 38. Americas Circulating Tumor DNA Test Kit Revenue Market Share by Country (2020-2025)
Figure 39. Americas Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 40. Americas Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 41. United States Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Circulating Tumor DNA Test Kit Sales Market Share by Region in 2025
Figure 46. APAC Circulating Tumor DNA Test Kit Revenue Market Share by Region (2020-2025)
Figure 47. APAC Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 48. APAC Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 49. China Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 53. India Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Circulating Tumor DNA Test Kit Sales Market Share by Country in 2025
Figure 57. Europe Circulating Tumor DNA Test Kit Revenue Market Share by Country (2020-2025)
Figure 58. Europe Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 59. Europe Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 60. Germany Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 61. France Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Circulating Tumor DNA Test Kit Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Circulating Tumor DNA Test Kit Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Circulating Tumor DNA Test Kit Sales Market Share by Application (2020-2025)
Figure 68. Egypt Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Circulating Tumor DNA Test Kit Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Circulating Tumor DNA Test Kit in 2025
Figure 74. Manufacturing Process Analysis of Circulating Tumor DNA Test Kit
Figure 75. Industry Chain Structure of Circulating Tumor DNA Test Kit
Figure 76. Channels of Distribution
Figure 77. Global Circulating Tumor DNA Test Kit Sales Market Forecast by Region (2026-2031)
Figure 78. Global Circulating Tumor DNA Test Kit Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Circulating Tumor DNA Test Kit Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Circulating Tumor DNA Test Kit Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Circulating Tumor DNA Test Kit Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Circulating Tumor DNA Test Kit Revenue Market Share Forecast by Application (2026-2031)
